HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBCL) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBCL) trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy aims to control Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new treatment called Talikabtagene autoleucel (a CAR-T cell therapy) for adults with B-cell cancers like leukemia or lymphoma that have come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target cancer c…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE2, PHASE3 • Sponsor: Health Institutes of Turkey • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New Dual-Target CAR t therapy aims to outsmart tough blood cancers
Disease control Recruiting nowThis early-phase study tests a new cell therapy called GF-CART01 in 18 adults aged 18-70 with B-cell blood cancers (like lymphoma) that have come back or not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target two markers (CD20 and …
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE1 • Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Last-Resort hope: new drug offered to lymphoma patients with no options left
Disease control AVAILABLEThis program gives people with certain types of lymphoma (like follicular lymphoma or diffuse large B-cell lymphoma) who have tried all other treatments access to an experimental drug called odronextamab. The goal is to provide a possible treatment option when no others are avail…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:39 UTC